APAC Liver Disease Alliance White Paper Launch

July 14, 2023

The APAC Liver Disease Alliance is the first platform in the Asia-Pacific region dedicated to addressing a wide range of liver diseases, including cirrhosis, hepatocellular carcinoma, and viral hepatitis. Formed in January 2023 it includes diagnostic companies Abbott and Roche, as well as academia, NGOs, liver coalitions, patient groups, and experts. Its primary goals are to promote prevention, early detection, timely referral, and research in the field of liver diseases.

We are excited to be participating in the upcoming White Paper Launch on 18 July 2023, and can share with you a sneak peek of the White Paper and an informative infographic!

View the summary.
View the infographic.

LiverWELL acknowledges the support of the Victorian Government.

We welcome people from all cultures, nationalities and religions. Being inclusive and providing equitable services is our commitment.

ABN 48 656 812 701

We acknowledge the traditional owners of the lands where we work - the lands of the Woi-Wurrung Wurundjeri people of the Kulin Nations. We express our gratitude to them for their continued care and curation of these lands and waters. We pay our respects to Elders past and present.

LiverWELL observes and honours the Kulin Nation's intrinsic connection to land, sky and water, and the creator Bunjil. LiverWELL is committed to being led and informed by Aboriginal and Torres Strait Islanders on bridging health outcomes for communities and improving liver health.

Topics you might be interested in

APAC Liver Disease Alliance White Paper Launch

Continue reading